journal1 ›› 2020, Vol. 28 ›› Issue (7): 763-765.DOI: 10.11852/zgetbjzz2019-1028

Previous Articles     Next Articles

Research progress on the treatment of Menkes disease

MAO Yu-ge, LI Yong-qin, QIN Jiong   

  1. Peking University People's Hospital,Beijing 100044,China
  • Received:2019-10-14 Online:2020-07-10 Published:2020-07-10
  • Contact: QIN Jiong,E-mail:qinjiong@pkuph.edu.cn

Menkes病的治疗研究进展

毛雨鸽, 李永钦, 秦炯   

  1. 北京大学人民医院,北京 100044
  • 通讯作者: 秦炯,E-mail:qinjiong@pkuph.edu.cn
  • 作者简介::毛雨鸽(1995-),女,江苏人,住院医师,本科学历,主要研究方向为儿童神经系统疾病。

Abstract: Menkes disease is a rare X-linked recessive genetic disease caused by ATP7A gene mutation,with varying clinical symptoms.Present treatments mainly include copper supplement,antiepileptic therapy,gene therapy and support therapy.With the development of molecular genetics technology,progress has been made on the treatment of Menkes disease.This review aims to provide reference for the individualized treatment of this disease.

Key words: Menkes disease, ATP7A gene, X-linked recessive genetic disease

摘要: Menkes病是一种罕见的X连锁隐性遗传病,由ATP7A基因突变引起,临床表现为神经系统症状及全身多系统功能障碍。目前治疗方法主要包括铜补充剂、抗癫痫治疗和支持治疗,随着分子遗传学技术的进步,在基因治疗方面也取得了一定进展。本文就以上治疗手段的研究进展作一综述,旨在为本病的个体化治疗提供参考。

关键词: Menkes病, ATP7A基因, X连锁隐性遗传病

CLC Number: